EichorEICHOR
Location: Pensacola Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Pensacola

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Ascension Sacred Heart · Hoffmann-La Roche · NCT06793215A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Nemours Children's Clinic - Pensacola · Children's Oncology Group · NCT06368817A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Nemours Children's Clinic - Pensacola · National Cancer Institute (NCI) · NCT05691478Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Nemours Children's Clinic - Pensacola · Alliance for Clinical Trials in Oncology · NCT07091617A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · AHF - Pensacola · Gilead Sciences · NCT07645287A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Emerald Coast Neurology - Airport Boulevard · Eli Lilly and Company · NCT07369011A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Nemours Children's Clinic - Pensacola · Children's Oncology Group · NCT04322318Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Gastro Health Research - Pensacola · Eli Lilly and Company · NCT06937086A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Out
Phase N/A · Sacred Heart Medical Oncology · Novartis Pharmaceuticals · NCT07091019ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Sacred Heart Hospital · Alliance for Clinical Trials in Oncology · NCT06876714GEMINI-NSCLC: NSCLC Biomarker Study
Phase N/A · Woodlands Medical Specialists · Tempus AI · NCT05236114A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults a
Phase 3 · GSK Investigational Site · ViiV Healthcare · NCT07650916Quality of End-of-Life Care for Children With Cancer
Phase N/A · Nemours Children's Clinic - Pensacola · Children's Oncology Group · NCT07412002Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Sacred Heart Hospital · National Cancer Institute (NCI) · NCT04269902A Study to Assess Growth in Children With Idiopathic Short Stature
Phase N/A · Nemours Children's Health System - Corporate Headquarters · BioMarin Pharmaceutical · NCT06309979A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Nemours Children's Clinic - Pensacola · Children's Oncology Group · NCT04293562A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Phase 3 · Panhandle Research and Medical Clinic · Xenon Pharmaceuticals Inc. · NCT06775379An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · Woodlands Medical Specialists · Novartis Pharmaceuticals · NCT05939414A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission o
Phase 3 · Avanza Medical Research Center · Hoffmann-La Roche · NCT06094010A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Phase 2 · Avanza Medical Research Center · Eli Lilly and Company · NCT07219173Walking Function in Diabetic Peripheral Neuropathy
NA · Florida Institute for Human and Machine Cognition · Florida Institute for Human and Machine Cognition · NCT05965336Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 1012 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949Project: Every Child for Younger Patients With Cancer
Phase N/A · Nemours Children's Clinic - Pensacola · Children's Oncology Group · NCT02402244Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Sacred Heart Hospital · ECOG-ACRIN Cancer Research Group · NCT04566328Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthis Investigational site 9811 · Anthos Therapeutics, Inc. · NCT05712200Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Ob
Phase 3 · Gastro Health Research - Pensacola · Eli Lilly and Company · NCT06937099Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macul
Phase 3 · Retina Specialty Institute · 4D Molecular Therapeutics · NCT07064759Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Phase 2 · Retina Specialty Institute · ONL Therapeutics · NCT06659445Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an An
Phase 3 · Nemours Children's Clinic - Pensacola · Children's Oncology Group · NCT06647953A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Phase 3 · Nemours Children's Clinic - Pensacola · National Cancer Institute (NCI) · NCT04166409
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.